MobbleOpen in Mobble ⇢
Health · Drug development · published 2026-10-20 · via Psychiatric Times

RAP-219 Shows Early Promise in Acute Bipolar Mania

Image via Psychiatric Times
Image via Psychiatric Times

A phase 2 study found that RAP-219 reduced acute bipolar mania symptoms, with notable improvements on the YMRS and generally favorable tolerability. The results are expected to support discussions with the FDA and planning for phase 3 testing.

Context

" labels. Need maybe blank line between sections. Output only. Need consider "2 short paragraphs (under 120 words total) of additional factual detail and background drawn ONLY from material above — entirely original wording, never copying source phrasing. If material is thin, write ONE careful paragraph situating the story in its wider topic without inventing specifics." Since material thin, maybe one paragraph is safer. But they asked "2 short paragraphs ... If material is thin, write ONE careful paragraph". We can write one paragraph under 120 words. But format says EXPANDED: 2 short paragraphs... If thin, one careful paragraph. We can choose one paragraph. Need situate in wider topic without inventing specifics. But "wider topic" could mention bipolar mania treatment development? Need not invent. We can write one paragraph: "The report concerns a phase 2 study of RAP-219 in acute bipolar mania. The summary states that symptoms improved notably on the YMRS and that tolerability was

Expanded detail and Context are AI-generated analysis; the linked article remains the authoritative source.
Read the full article at Psychiatric Times →
Related stories
Gilead oral IBD therapy clears symptoms in Phase 2 trial · Drug development
Oral RSV Antiviral Eases Symptoms Without Meeting Main Trial Goal · Infectious disease
Phase IIb Data Suggest Benefit for Tulisokibart in Hidradenitis Suppurativa · Drug development
Leaked Phase III Data Show mRNA Vaccine Improves Melanoma Outcomes · Cancer research
This summary is Al-enhanced to contain extended analysis and broader social context. The original is {NAME); the linked article is the authoritative source. Original headline: “Positive Topline Results From Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania.” Browse more stories.